Matinas BioPharma Holdings, Inc.

MTNB · AMEX
Analyze with AI
$0.7601−$0.0299 (−3.78%)
At close:Dec 15, 2025, 7:17 PM UTC
$0.7601+$0.00 (+0%)
After hours:Dec 15, 2025, 7:17 PM UTC
P/E TTM-0.24
P/B TTM0.64
P/S TTM4.39
Dividend Yield0%
EPS-$3.42
Beta1.327
Valuation
PEG Ratio-0.02
FCF Yield-213.49%
EV / EBITDA-0.13
Quality
ROIC-103.36%
Gross Margin23.80%
Cash Conv. Ratio0.53
Growth
Revenue 3Y CAGR-100.00%
FCF Growth-2.51%
Safety
Net Debt / EBITDA0.36
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-39.84

Matinas BioPharma Holdings, Inc. (MTNB) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Matinas BioPharma Holdings, Inc. (MTNB) stock price today?

As of Dec 15, 2025, 7:17 PM UTC, Matinas BioPharma Holdings, Inc. (MTNB) stock is trading at $0.7601. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date MTNB stock quotes for informed trading decisions.

What is Matinas BioPharma Holdings, Inc.'s market capitalization?

Matinas BioPharma Holdings, Inc. (MTNB) has a market capitalization of approximately $4.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Matinas BioPharma Holdings, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the MTNB stock price changes.

What is the 52-week range for Matinas BioPharma Holdings, Inc. stock?

Matinas BioPharma Holdings, Inc. (MTNB) stock has traded in a 52-week range of $0.475 — $3.09. The 52-week range shows the highest and lowest prices at which MTNB traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Matinas BioPharma Holdings, Inc. stock price to this range provides context for recent price action.

How much trading volume does Matinas BioPharma Holdings, Inc. stock have?

Matinas BioPharma Holdings, Inc. (MTNB) stock recently traded approximately 27.7K shares. Trading volume indicates market liquidity and investor interest in MTNB. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Matinas BioPharma Holdings, Inc. stock.

Does Matinas BioPharma Holdings, Inc. pay dividends to shareholders?

Yes, Matinas BioPharma Holdings, Inc. (MTNB) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Matinas BioPharma Holdings, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Matinas BioPharma Holdings, Inc.'s intraday price range?

Today, Matinas BioPharma Holdings, Inc. (MTNB) stock has traded in a range of $0.722 — $0.8363. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring MTNB's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Matinas BioPharma Holdings, Inc. stock data?

AlphaPilot sources real-time MTNB stock quotes, fundamental financial data, and historical price charts for Matinas BioPharma Holdings, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Matinas BioPharma Holdings, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of MTNB stock performance.